MoonLake Immunotherapeutics (MLTX) shares outstanding

Shares outstanding · fiscal 2025
64.46M

MoonLake Immunotherapeutics (MLTX) had 64.46M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.5% higher than the 62.87M of fiscal 2024. Figures as of 18 Nov 2026, 12:05 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
64.46M
Change on fiscal 2024
+2.5%
Highest on record
360.00Mfiscal 2021
Lowest on record
38.98Mfiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

MoonLake Immunotherapeutics shares outstanding, in more detail

The market data feed counts 85.11M shares outstanding today.

Across the 5 fiscal years on record (2021–2025), the highest was 360.00M in fiscal 2021 and the lowest 38.98M in fiscal 2022.

History · 5 fiscal years

Shares outstanding by fiscal year

MoonLake Immunotherapeutics shares outstanding, year by year

MoonLake Immunotherapeutics (MLTX) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202564.46M 2.5% up
202462.87M 28.0% up
202349.12M 26.0% up
202238.98M 89.2% down
2021360.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on MLTX

MoonLake Immunotherapeutics, figure by figure

MoonLake Immunotherapeutics (MLTX) overview: price, valuation and scorecard

MoonLake Immunotherapeutics shares outstanding: questions and answers

How many shares does MoonLake Immunotherapeutics have?

MoonLake Immunotherapeutics (MLTX) had 64.46M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.5% higher than the 62.87M of fiscal 2024. The market data feed counts 85.11M shares outstanding today.

What are the highest and lowest diluted share count figures on record for MoonLake Immunotherapeutics?

Across the 5 fiscal years on record (2021–2025), the highest was 360.00M in fiscal 2021 and the lowest 38.98M in fiscal 2022.

How is MoonLake Immunotherapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For MoonLake Immunotherapeutics it is on record here for 5 fiscal years, 2021 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “MoonLake Immunotherapeutics (MLTX) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/MLTX/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.